FGF23 Concentrations Vary With Disease Status in Autosomal Dominant Hypophosphatemic Rickets

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Bone and Mineral Research

• Publication date

  2007-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1359/jbmr.070107PMID 17227222
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation of C‐Terminal and Intact FGF‐23 by Dietary Phosphate in Men and Women

  2006influential reference
• Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D.

  2006cited by this paper
• Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia.

  2006cited by this paper
• Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men.

  2006cited by this paper
• Fibroblast growth factor 23: roles in health and disease.

  2005cited by this paper
• Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men.

  2005cited by this paper
• Vitamin D and phosphate regulate fibroblast growth factor-23 in K-562 cells.

  2005cited by this paper
• Circulating FGF-23 Is Regulated by 1α,25-Dihydroxyvitamin D3 and Phosphorus in Vivo*

  2005cited by this paper
• Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis.

  2004cited by this paper
• Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders.

  2004cited by this paper
• The Autosomal Dominant Hypophosphatemic Rickets R176Q Mutation in Fibroblast Growth Factor 23 Resists Proteolytic Cleavage and Enhances in Vivo Biological Potency*

  2003cited by this paper
• Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.

  2003cited by this paper
• Serum FGF23 Levels in Normal and Disordered Phosphorus Homeostasis

  2003cited by this paper
• Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.

  2003cited by this paper
• Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers.

  2003cited by this paper
• Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia.

  2002cited by this paper
• Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo.

  2002cited by this paper
• Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23.

  2001cited by this paper
• Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

  2000cited by this paper
• Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder.

  1997influential reference
• Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.

  1985cited by this paper
• X-linked hypophosphatemia: effect of calcitriol on renal handling of phosphate, serum phosphate, and bone mineralization.

  1981cited by this paper
• NOMOGRAM FOR DERIVATION OF RENAL THRESHOLD PHOSPHATE CONCENTRATION

  1975cited by this paper
• Familial hypophosphatemic rickets showing autosomal dominant inheritance.

  1971cited by this paper
• Familial hypophosphatemic rickets showing autosomal dominant inheritance.

  1971cited by this paper

• Personalized Treatment Pathways for Adult Osteomalacia

  2026cites this paper
• Burosumab treatment for fibroblast growth factor-23-associated hypophosphatemia in an adult patient with severe fibrous dysplasia in McCune–Albright syndrome: case report and review of the literature

  2025cites this paper
• Non-Classical Effects of FGF23: Molecular and Clinical Features

  2024cites this paper
• FGF23 as a Potential Pathophysiological Factor in Peripheral Arterial Disease Associated with Chronic Kidney Disease

  2024cites this paper
• Meta-analysis and systematic review: burosumab as a promising treatment for children with X-linked hypophosphatemia

  2024cites this paper
• A Novel Pathogenic Variant in Fibroblast Growth Factor 23 outside the Furin-Recognizing RXXR Motif in an Autosomal Dominant Hypophosphatemic Rickets Patient

  2024cites this paper
• A case report of autosomal dominant hypophosphatemic rickets due to a mutation in the FGF23 gene in an adult: diagnostic difficulties

  2024cites this paper
• Regulation of FGF23 Production in Osteocytes

  2024cites this paper
• Mineral Metabolism in Children: Interrelation between Vitamin D and FGF23

  2023cites this paper
• Osteocyte Egln1/Phd2 links oxygen sensing and biomineralization via FGF23

  2023influential citation
• Tumor-induced osteomalacia.

  2023cites this paper
• Bone marrow sinusoidal endothelial cells are a site of Fgf23 upregulation in a mouse model of iron deficiency anemia

  2023cites this paper
• Advances in understanding of phosphate homeostasis and related disorders.

  2022cites this paper
• Global guidance for the recognition, diagnosis, and management of tumor‐induced osteomalacia

  2022cites this paper
• Approach to Hypophosphatemic Rickets

  2022cites this paper
• Hypophosphatemia: A Practical Guide to Evaluation and Management.

  2022cites this paper
• Fibroblast growth factor-23 rs7955866 polymorphism and risk of chronic kidney disease

  2022cites this paper
• Osteocytes and the pathogenesis of hypophosphatemic rickets

  2022cites this paper
• Determination of iFGF23 Upper Reference Limits (URL) in healthy pediatric population, for its better correct use

  2022cites this paper
• Bone characteristics of autosomal dominant hypophosphatemic rickets patients.

  2022cites this paper
• Pathogenesis of FGF23-Related Hypophosphatemic Diseases Including X-linked Hypophosphatemia

  2022cites this paper
• Phosphatonins

  2021cites this paper
• Genetic basis of hereditary hypophosphataemic rickets and phenotype presentation in children and adults.

  2021cites this paper
• Pathophysiological Implications of Imbalances in Fibroblast Growth Factor 23 in the Development of Diabetes

  2021cites this paper
• In Vivo Analysis of the Contribution of Proprotein Convertases to the Processing of FGF23

  2021cites this paper
• FGF23 functions and disease.

  2021cites this paper
• FGF23 as a drug target

  2021cites this paper
• FGF23 and Hypophosphatemic Rickets/Osteomalacia

  2021cites this paper
• The discovery of FGF23—a historic view

  2021cites this paper
• The Molecular Basis of Calcium and Phosphorus Inherited Metabolic Disorders

  2021cites this paper
• Fibroblast Growth Factor-23 and Matrix Extracellular Phosphoglycoprotein Levels in Healthy Children and, Pregnant and Puerperal Women

  2020cites this paper
• Calcium and phosphorus disorders

  2020cites this paper
• Oral Iron Replacement Normalizes Fibroblast Growth Factor 23 in Iron‐Deficient Patients With Autosomal Dominant Hypophosphatemic Rickets

  2020cites this paper
• Fibroblast growth factor 23

  2020cites this paper
• FGF23-related hypophosphatemic rickets/osteomalacia: diagnosis and new treatment.

  2020cites this paper
• C‐Terminal, but Not Intact, FGF23 and EPO Are Strongly Correlatively Elevated in Patients With Gain‐of‐Function Mutations in HIF2A: Clinical Evidence for EPO Regulating FGF23

  2020cites this paper
• Phosphorus homeostasis and related disorders

  2020cites this paper
• Iron deficiency plays essential roles in the trigger, treatment, and prognosis of autosomal dominant hypophosphatemic rickets

  2020cites this paper
• Congenital Conditions of Hypophosphatemia in Children

  2020cites this paper
• The Causes of Hypo- and Hyperphosphatemia in Humans

  2020cites this paper
• Earlier Onset in Autosomal Dominant Hypophosphatemic Rickets of R179 than R176 Mutations in Fibroblast Growth Factor 23: Report of 20 Chinese Cases and Review of the Literature

  2019cites this paper
• The EPO-FGF23 Signaling Pathway in Erythroid Progenitor Cells: Opening a New Area of Research

  2019cites this paper
• Phosphorus Disorders: Hypophosphatemic Rickets

  2019cites this paper
• Phosphate Metabolism, Hyperphosphatemia, and Hypophosphatemia

  2019cites this paper
• Interaction between serum FGF-23 and PTH in renal phosphate excretion, a case-control study in hypoparathyroid patients

  2019cites this paper
• Oral Iron for Prevention and Treatment of Rickets and Osteomalacia in Autosomal Dominant Hypophosphatemia

  2019cites this paper
• FGF23 and Bone and Mineral Metabolism.

  2019cites this paper
• Role of Fibroblast Growth Factor 23 on Cardiac Remodelling in Experimental Heart Failure

  2019cites this paper
• FGF23 and Associated Disorders of Phosphate Wasting.

  2019influential citation
• Regulation of Fibroblast Growth Factor 23 by Iron, EPO, and HIF

  2019cites this paper
• The Bone–FGF23–Klotho Axis and Associated Diseases

  2019cites this paper
• Disorders of Phosphate Homeostasis

  2018cites this paper
• Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23 gene in child from Russia

  2018cites this paper
• Mutational Analysis in Hypophosphatemic Rickets of Tamil Nadu– A Rare Case Report

  2018cites this paper
• Tumor-induced osteomalacia

  2018cites this paper
• FGF23 beyond Phosphotropic Hormone.

  2018cites this paper
• Targeting Fibroblast Growth Factor 23 Signaling with Antibodies and Inhibitors, Is There a Rationale?

  2018cites this paper
• Hereditary hypophosphatemic rickets with hypercalciuria: pathophysiology, clinical presentation, diagnosis and therapy

  2018cites this paper
• Phosphate wasting disorders in adults

  2018cites this paper
• Chapter 40 – Heritable Renal Phosphate Wasting Disorders

  2018cites this paper
• X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment.

  2018cites this paper
• Genetic diseases resulting from disordered FGF23/klotho biology.

  2017cites this paper
• 18 Monogenic Phosphate Balance Disorders

  2017cites this paper
• Genetic Causes of Rickets

  2017cites this paper
• Hormonal Regulation of Phosphorus Homeostasis: Parathyroid Hormone, Fibroblast Growth Factor 23, and Klotho

  2017cites this paper
• IRON REPLACEMENT AS A THERAPEUTIC APPROACH FOR RENAL PHOSPHATE WASTING WITH ASSOCIATED IRON DEFICIENCY

  2017cites this paper
• Heritable and acquired disorders of phosphate metabolism: Etiologies involving FGF23 and current therapeutics.

  2017cites this paper
• The metabolic bone disease associated with the Hyp mutation is independent of osteoblastic HIF1α expression

  2017cites this paper
• Conditional Deletion of Murine Fgf23: Interruption of the Normal Skeletal Responses to Phosphate Challenge and Rescue of Genetic Hypophosphatemia

  2016cites this paper
• Serum fibroblast growth factor 23, serum iron and bone mineral density in premenopausal women.

  2016cites this paper
• Altération du phénotype chondrocytaire : Rôle de l’homéostasie locale de facteurs modulant la balance Pi/Ppi

  2016influential citation
• Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23

  2015cites this paper
• A Practical Clinical Approach to Paediatric Phosphate Disorders.

  2015cites this paper
• Clinical significance of FGF-23 in Chronic Kidney Disease Patients

  2015cites this paper
• Coupling FGF 23 Production and Cleavage : Iron Deficiency , Rickets and Kidney Disease

  2015cites this paper
• Iron Supplementation Associated With Loss of Phenotype in Autosomal Dominant Hypophosphatemic Rickets.

  2015cites this paper
• Hypophosphatemic Rickets: Lessons from Disrupted FGF23 Control of Phosphorus Homeostasis

  2015cites this paper
• FGF23-FGF Receptor/Klotho Pathway as a New Drug Target for Disorders of Bone and Mineral Metabolism

  2015cites this paper
• Tumor-induced osteomalacia—a diagnostic dilemma for an orthopedic surgeon

  2014cites this paper
• A compound heterozygous mutation in SLC34A3 causes hereditary hypophosphatemic rickets with hypercalciuria in a Chinese patient.

  2014cites this paper
• Diagnostic Modalities for FGF23-Producing Tumors in Patients with Tumor-Induced Osteomalacia

  2014cites this paper
• Utilidad clínica de la determinación del factor de crecimiento de los fibroblastos 23 en la valoración de pacientes con osteomalacia

  2014cites this paper
• Osteocyte Communication with the Kidney Via the Production of FGF23: Remote Control of Phosphate Homeostasis

  2014cites this paper
• Iron and fibroblast growth factor 23 in X-linked hypophosphatemia.

  2014cites this paper
• Genetic rescue of glycosylation-deficient Fgf23 in the Galnt3 knockout mouse.

  2014cites this paper
• [Clinical usefulness of the determination of fibroblast growth factor 23 in the evaluation of patients with osteomalacia].

  2014cites this paper
• Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease

  2014cites this paper
• Neonatal Iron Deficiency Causes Abnormal Phosphate Metabolism by Elevating FGF23 in Normal and ADHR Mice

  2014cites this paper
• Erratum to: New mouse models for metabolic bone diseases generated by genome-wide ENU mutagenesis

  2014cites this paper
• Fibroblast growth factor 23

  2014cites this paper
• The rachitic tooth.

  2014cites this paper
• Primary Disorders of Phosphate Metabolism

  2014cites this paper
• Hip fracture leading to the diagnosis of autosomal dominant hypophosphatemic rickets. A case report.

  2013cites this paper
• Autosomal dominant hypophosphatemic rickets in an 85 year old woman: characterization of her disease from infancy through adulthood.

  2013cites this paper
• Osteocyte regulation of phosphate homeostasis and bone mineralization underlies the pathophysiology of the heritable disorders of rickets and osteomalacia.

  2013cites this paper
• Effect of a 300 000-IU loading dose of ergocalciferol (Vitamin D2) on circulating 1,25(OH)2-vitamin D and fibroblast growth factor-23 (FGF-23) in vitamin D insufficiency.

  2013cites this paper
• Exome sequencing reveals FAM20c mutations associated with fibroblast growth factor 23–related hypophosphatemia, dental anomalies, and ectopic calcification

  2013cites this paper
• The changing face of hypophosphatemic disorders in the FGF-23 era.

  2013cites this paper
• Tumor-Induced Osteomalacia Caused by a Bone Tumor in the Ulna: A Case Report.

  2013cites this paper
• Hereditary rickets. How genetic alterations explain the biochemical and clinical phenotypes.

  2013cites this paper